Abstract B007: Vandetanib abrogates antiestrogen resistance in MAPK-driven ER+ breast cancer by halting key intracellular signaling pathways and multiple druggable kinases
Authors: Rasha T Kakati, Austin Whitman, Hyunsoo Kim, Philip M Spanheimer
Published: 2024-02-01
DOI:
10.1158/1538-7445.advbc23-b007
Source:
Full article
Abstract
Abstract